MELINDA RICHEY: Open Payments
NPI 1710983655 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 20 payments from 13 companies in 2025. Trend: 2023 $1,100 · 2024 $759 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $212 |
| GENZYME CORPORATION | 2 | $52 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $29 |
| LEO Pharma Inc. | 1 | $27 |
| Almirall LLC | 1 | $26 |
| Janssen Biotech, Inc. | 1 | $23 |
| Kerecis Limited | 1 | $23 |
| ABBVIE INC. | 1 | $23 |
| Organon LLC | 2 | $22 |
Products named: COSENTYX, DUPIXENT, Rhapsido, BLU-U, ANZUPGO, Cordran, TREMFYA, Kerecis SurgiClose.
Industry payments across CO — which companies pay providers there.
